Selected furanochalcones as inhibitors of monoamine oxidase

Bioorg Med Chem Lett. 2013 Sep 1;23(17):4985-9. doi: 10.1016/j.bmcl.2013.06.050. Epub 2013 Jun 28.

Abstract

The validity of the chalcone scaffold for the design of inhibitors of monoamine oxidase has previously been illustrated. In a systematic attempt to investigate the effect of heterocyclic substitution on the monoamine oxidase inhibitory properties of this versatile scaffold, a series of furanochalcones were synthesized. The results demonstrate that these furan substituted phenylpropenones exhibited moderate to good inhibitory activities towards MAO-B, but showed weak or no inhibition of the MAO-A enzyme. The most active compound, 2E-3-(5-chlorofuran-2-yl)-1-(3-chlorophenyl)prop-2-en-1-one, exhibited an IC50 value of 0.174 μM for the inhibition of MAO-B and 28.6 μM for the inhibition of MAO-A. Interestingly, contrary to data previously reported for chalcones, these furan substituted derivatives acted as reversible inhibitors, while kinetic analysis revealed a competitive mode of binding.

Keywords: Chalcone; Competitive; MAO-B; Monoamine oxidase; Reversible inhibition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chalcones / chemistry*
  • Chalcones / pharmacology*
  • Furans / chemistry
  • Furans / pharmacology
  • Humans
  • Monoamine Oxidase / metabolism
  • Monoamine Oxidase Inhibitors / chemistry*
  • Monoamine Oxidase Inhibitors / pharmacology*
  • Recombinant Proteins / metabolism

Substances

  • Chalcones
  • Furans
  • Monoamine Oxidase Inhibitors
  • Recombinant Proteins
  • Monoamine Oxidase